Opportunities and Challenges for Selected Emerging Technologies in Cancer Epidemiology: Mitochondrial, Epigenomic, Metabolomic, and Telomerase Profiling
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Remarkable progress has been made in the last decade in new methods for biologic measurements using sophisticated technologies that go beyond the established genome, proteome, and gene expression platforms. These methods and technologies create opportunities to enhance cancer epidemiologic studies. In this article, we describe several emerging technologies and evaluate their potential in epidemiologic studies. We review the background, assays, methods, and challenges and offer examples of the use of mitochondrial DNA and copy number assessments, epigenomic profiling (including methylation, histone modification, miRNAs, and chromatin condensation), metabolite profiling (metabolomics), and telomere measurements. We map the volume of literature referring to each one of these measurement tools and the extent to which efforts have been made at knowledge integration (e.g., systematic reviews and meta-analyses). We also clarify strengths and weaknesses of the existing platforms and the range of type of samples that can be tested with each of them. These measurement tools can be used in identifying at-risk populations and providing novel markers of survival and treatment response. Rigorous analytic and validation standards, transparent availability of massive data, and integration in large-scale evidence are essential in fulfilling the potential of these technologies. Cancer Epidemiol Biomarkers Prev; 22(2); 189–200. ©2012 AACR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., Vandenbroucke, J. P., & Initiative, F. T. S. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040296 · Cited by 23,020
von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., & Vandenbroucke, J. P. (2007) · Preventive Medicine · doi:10.1016/j.ypmed.2007.08.012 · Cited by 2,698
Li, G., Ruan, X., Auerbach, R. K., Sandhu, K. S., Zheng, M., Wang, P., Poh, H. M., Goh, Y., Lim, J., Zhang, J., et al. (2012) · Cell · doi:10.1016/j.cell.2011.12.014 · Cited by 1,232 · cited 1×
“times of the genome, proteome, transcriptome, and metabolome has been recently described (144), and as platforms become less expensive, such combined assessments”
Human metabolic phenotype diversity and its association with diet and blood pressure
Holmes, E., Loo, R. L., Stamler, J., Bictash, M., Yap, I. K. S., Chan, Q., Ebbels, T., De Iorio, M., Brown, I. J., Veselkov, K. A., et al. (2008) · Nature · doi:10.1038/nature06882 · Cited by 1,054 · cited 1×
“cellular activity at the functional level and, hence, can be used to discern mechanistic information during normal and disease states (104-107).”
An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues
Liu, C.-G., Calin, G. A., Meloon, B., Gamliel, N., Sevignani, C., Ferracin, M., Dumitru, C. D., Shimizu, M., Zupo, S., Dono, M., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403293101 · Cited by 948 · cited 1×
“Highthroughput miRNA quantification technologies such as the miRNA microarray (36-41),”
Hu, Z., Chen, X., Zhao, Y., Tian, T., Jin, G., Shu, Y., Chen, Y., Xu, L., Zen, K., Zhang, C., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.9342 · Cited by 798 · cited 2×
“mtDNA alterations GermlinemtDNA for screening populations for breast cancer (3, 5, 189, 190), breast and esophageal cancer (4), kidney cancer (191), pancreatic cancer (15); to evaluate longterm survival in breast cancer (192), somatic mtDNA mutation to identify risk of lung cancer (193, 194) Epigenetic profiling Methy…”
Public Availability of Published Research Data in High-Impact Journals
Alsheikh-Ali, A. A., Qureshi, W., Al-Mallah, M. H., & Ioannidis, J. P. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024357 · Cited by 363
Self-citationbioinformatics tools for mass spectroscopy-based metabolomic data processing and analysis
Sugimoto, M., Kawakami, M., Robert, M., Soga, T., & Tomita, M. (2012) · Current Bioinformatics · doi:10.2174/157489312799304431 · Cited by 307 · cited 1×
“Advancements in automatic sample preparation and handling, robotic sample delivery systems, automatic data processing, and multivariate statistical approaches can help streamline and standardize the process, but there are a number of different platforms (113-120) and familiarity is required for their proper use.”
Telomere Length Assessment in Human Archival Tissues
Meeker, A. K., Gage, W. R., Hicks, J. L., Simon, I., Coffman, J. R., Platz, E. A., March, G. E., & De Marzo, A. M. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62553-9 · Cited by 209
Bictash, M., Ebbels, T. M., Chan, Q., Loo, R. L., Yap, I. K. S., Brown, I. J., de Iorio, M., Daviglus, M. L., Holmes, E., Stamler, J., et al. (2010) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.10.001 · Cited by 140
Cited by
Livestock metabolomics and the livestock metabolome: A systematic review
Goldansaz, S. A., Guo, A. C., Sajed, T., Steele, M. A., Plastow, G. S., & Wishart, D. S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177675 · Cited by 379
Transforming Epidemiology for 21st Century Medicine and Public Health
Khoury, M. J., Lam, T. K., Ioannidis, J. P. A., Hartge, P., Spitz, M. R., Buring, J. E., Chanock, S. J., Croyle, R. T., Goddard, K. A., Ginsburg, G. S., et al. (2013) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-0146 · Cited by 119
Self-citationBiological embedding of early‐life exposures and disease risk in humans: a role for DNA methylation
Demetriou, C. A., van Veldhoven, K., Relton, C., Stringhini, S., Kyriacou, K., & Vineis, P. (2015) · European Journal of Clinical Investigation · doi:10.1111/eci.12406 · Cited by 95
Metadata
- Authors
- Verma, M., Khoury, M. J., & Ioannidis, J. P. A.
- Venue
- Cancer Epidemiology, Biomarkers & Prevention
- Published
- 2013-02-01
- Volume
- 22
- Issue
- 2
- Pages
- 189-200
- ISSN
- 1055-9965 (ISSN-L)
- 1538-7755
- OpenAlex
- W2116661422
- Cited by
- 38
- References
- 11
- FWCI
- 1.97
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Opportunities and Challenges for Selected Emerging Technologies in Cancer Epidemiology: Mitochondrial, Epigenomic, Metabolomic, and Telomerase Profiling. https://app.cochat.ai/papers/10.1158/1055-9965.epi-12-1263
- The paper
- Verma, M., Khoury, M. J., & Ioannidis, J. P. A. (2013). Opportunities and Challenges for Selected Emerging Technologies in Cancer Epidemiology: Mitochondrial, Epigenomic, Metabolomic, and Telomerase Profiling. Cancer Epidemiology, Biomarkers & Prevention. https://doi.org/10.1158/1055-9965.epi-12-1263
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.